COMMUNIQUÉS West-GlobeNewswire

Immunomedics Appoints Barbara G. Duncan to Board of Directors
07/03/2019
MORRIS PLAINS, N.J., March 07, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]
Align Technology Announces Distribution Agreement With Benco Dental for iTero Element® Intraoral Scanners
07/03/2019
SAN JOSE, Calif. and PITTSTON, Pa., March 07, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN ) today announced a distribution agreement with Benco Dental, the largest privately-owned dental distributor in [...]
OncoMed Announces Fourth Quarter and Full Year 2018 Financial Results
07/03/2019
REDWOOD CITY, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, [...]
Administrative Law Judge Determines 3Shape Infringes Three Align Patents; Initial Determination Declines to Find Section 337 Violation
07/03/2019
Align Will Seek Commission Review of ALJ’s Initial Determination ALJ Declines to Address Two Other Align Patents because of Delay Resulting from U.S. Government Shutdown SAN JOSE, Calif., March 07, 2019 (GLOBE NEWSWIRE [...]
Protech Home Medical Announces Closing of $15 Million Bought Deal Offering
07/03/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CINCINNATI, March 07, 2019 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (the " Company ") (TSXV: PTQ) is pleased to [...]
Aleafia Health to Graduate to Toronto Stock Exchange
07/03/2019
TORONTO, March 07, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“ Aleafia Health ” or the “ Company ”) announced today that the Company has received conditional approval from the [...]
RavenQuest Announces Non-Brokered Private Placement
07/03/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS VANCOUVER, British Columbia, March [...]
Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities
07/03/2019
Orphazyme A/S Company announcement No. 08/2019 Company Registration No. 32266355 Copenhagen, Denmark, March 7, 2019 – Pursuant to the Market Abuse Regulation article 19, Orphazyme A/S, CVR no. 32266355 (“Orphazyme”), [...]
SRS Health to Showcase Top-Rated Orthopedic Solutions Suite at 2019 American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting
07/03/2019
Recent Top-Rating in KLAS Orthopedic EMR 2018 Report* Reinforces Healthcare IT Pioneers Reputation as the Best Partner for High-Performance Orthopedic Professionals MONTVALE, N.J., March 07, 2019 (GLOBE NEWSWIRE) -- SRS [...]
Canopy Rivers Portfolio Company Headset Enters Into Alliance With Global Data Analytics Giant Nielsen
07/03/2019
TORONTO, March 07, 2019 (GLOBE NEWSWIRE) -- Canopy Rivers Inc. (the “ Company ” or “ Canopy Rivers ”) (TSXV: RIV) congratulates its portfolio company Headset, Inc. (“ Headset ”) on the formation of its landmark [...]
PRA Blue Bell Named 2019 Top Workplace by Philadelphia Inquirer
07/03/2019
BLUE BELL, Pa., March 07, 2019 (GLOBE NEWSWIRE) -- PRA Health Sciences is delighted to be included as the only CRO on the Philadelphia Inquirer’s list of Top Workplaces for 2019. The best employers around the country [...]
Santé Canada autorise Medexus à distribuer tréosulfan au Canada
07/03/2019
Début des envois aux hôpitaux dans le cadre du Programme d’accès spécial Des plans sont en cours pour demander un enregistrement complet au Canada MONTRÉAL, 07 mars 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc [...]
Successful Treatment of “London Patient” Underscores Clinical Potential of Enochian Biosciences’ Gene Modified Cellular Therapy for HIV
07/03/2019
Enochian developing ENOB-HV-01 an autologous cell therapy as a potentially curative treatment for HIV LOS ANGELES, March 07, 2019 (GLOBE NEWSWIRE) -- Enochian Biosciences, Inc. (Nasdaq: ENOB), a biotechnology company [...]
Xbrane publishes published prospectus in connection with fully guaranteed rights issue of approximately SEK 59 million
07/03/2019
Press release 7 March 201 9 NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, WITHIN OR INTO THE AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, THE [...]
OSE Immunotherapeutics Presents its Novel Bispecific Checkpoint Inhibitor Platform, Targeting PD-1 and Innovative Targets at the 2019 World Immunotherapy Congress
07/03/2019
NANTES, France, March 07, 2019 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN: FR0012127173; Mnémo: OSE), announces that it has disclosed its novel bispecific checkpoint inhibitor (BiCKI ® ) platform in a plenary [...]
Oxurion NV Business Update - FY 2018
07/03/2019
Significant Progress with Novel Diabetic Eye Disease Portfolio Positive Topline Results from Phase 1/2 evaluating THR-317 for treatment of DME Multiple Clinical Readouts Expected towards the end of H2 2019 Total Cash [...]
Phoenix Life Breaks Ground for Network of Community Clinics and Dispensing Pharmacies for the Republic of Vanuatu
07/03/2019
DENVER, CO, March 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”, ”the Company”), an international adaptive healthcare solutions company, today [...]
Aptevo Announces Pricing of $22 Million Offering of Common Stock and Warrants
07/03/2019
SEATTLE, March 07, 2019 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused on developing novel oncology, autoimmune and hematology therapeutics, today announced the pricing of ( [...]
Zealand Pharma announces full-year 2018 results, strong cash position to support pipeline progress
07/03/2019
Company announcement – No. 03 / 2019 Zealand Pharma announces full-year 2018 results, strong cash position to support pipeline progress Copenhagen, March 7, 2019 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR No. [...]

Pages